New ECT technique aims to treat severe depression with fewer memory problems
NCT ID NCT05402657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way of giving electroconvulsive therapy (ECT) for severe depression. The goal was to see if a different electrode placement on the head could reduce memory loss while still effectively treating depression. 156 adults with severe depression took part, receiving either the standard or the new ECT placement over about 4 weeks, followed by 24 weeks of follow-up. The study compared how well each type worked and how it affected memory.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
156 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * DSM-5 diagnosis\* of major depressive episode (unipolar or bipolar) * HRSD-17 score ≥ 17 at Screening * At least 18 years old * Able to tolerate washout of prohibited medications and restriction on benzodiazepine dosage, as determined by patient's own treating psychiatrist. * ECT indicated for treatment of depression, as determined by own treating referring psychiatrist and confirmed by research evaluations (e.g., diagnosis of depression) * Willing and able to participate in research and comply with study requirements * Sufficient proficiency in spoken English to ensure validity of neuropsychological testing (e.g., worked or studied in an English-speaking context or equivalent) Exclusion Criteria: * History of schizophrenia, schizoaffective disorder, other \[non-mood disorder\] psychosis, or rapid cycling bipolar disorder (DSM-5 diagnoses\*) * Current manic episode, hypomanic episode, or major depressive episode with mixed features (DSM-5 diagnoses\*) * Alcohol or substance use disorder (other than caffeine or nicotine) present in the past month, or is likely to be present during the 24-week study period as determined by study physician evaluation * Diagnosis of amnestic disorder, dementia, delirium, or epilepsy, as determined by study physician evaluation and medical history * Central nervous system disease or brain injury that has resulted in significant cognitive impact, as determined by study physician evaluation and medical history * Serious or unstable medical condition, as determined by study physician evaluation and medical history * If female of childbearing potential: a) pregnancy as determined by pregnancy urine screen * Completed an acute course of ECT during the past 2 months, as determined by treatment history * Received any ECT during the past 2 weeks * Failed an adequate course of ECT (i.e., 8 ECT treatments ) in the current depressive episode * Patients who are prisoners, and those who lack capacity to make medical decisions (as judged by their own treating psychiatrist) * Currently enrolled in another interventional clinical trial * Currently using another investigational device or product * DSM-5 psychiatric diagnoses will be assessed and confirmed using the Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998) Version 7.0.2 for DSM-5, administered by research team members.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Major depressive episode are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University
Atlanta, Georgia, 30322, United States
-
Gold Coast University Hospital (GCUH)
Gold Coast, Queensland, 4215, Australia
-
Medical College of Georgia, Augusta University
Augusta, Georgia, 30912, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Ramsay Clinic Albert Road
Melbourne, Victoria, 3004, Australia
-
Ramsay Clinic Lakeside
Warners Bay, New South Wales, 2282, Australia
-
Ramsay Clinic Northside
Sydney, New South Wales, 2065, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves vs. depression: can focused ultrasound lift mood?
- Can brain activity reveal why some people with depression lose motivation and pleasure?
- Can a targeted magnetic pulse rewire the depressed brain?
- Can a simpler brain stimulation match the gold standard for depression?
- Magnetic brain pulses could offer Drug-Free hope for teen depression
- Decoding depression: sleep rhythms as biomarkers?